Cardiomyocyte function associated with hyperactivity and/or hypertension in genetic models of LV hypertrophy

Bradley M Palmer1, Zengyi Chen, Richard R Lachapelle

  • 1Dept. of Molecular Physiology and Biophysics, Univ. of Vermont, Burlington, VT 05405, USA. palmer@physiology.med.uvm.edu

Insights

Hypertension alone does not fully explain left ventricular hypertrophy and impaired function in rats. Hyperactivity, especially in males, interacts with hypertension to diminish cardiomyocyte function.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Animal Models of Disease

Background:

  • Left ventricular (LV) hypertrophy is a complex condition.
  • Its development and functional consequences are influenced by factors like hypertension (HT) and hyperactive (HA) behavior.
  • Genetic rat models offer insights into these influences.

Purpose of the Study:

  • To investigate the distinct and combined roles of hypertension and hyperactive behavior on cardiomyocyte function.
  • To compare cardiac dynamics in genetically modified rat strains with specific traits.
  • To elucidate the mechanisms underlying LV hypertrophy and impaired function in the spontaneously hypertensive rat (SHR).

Main Methods:

  • Isolated cardiomyocytes from WKY, WKHT, WKHA, and SHR rat strains (male and female).
  • Pacing cardiomyocytes at 2, 3, and 4 Hz at 37°C with 1.2 mM external Ca2+.
  • Simultaneous recording of intracellular calcium ([Ca2+]i) and sarcomere shortening dynamics.

Main Results:

  • WKHT rats showed enhanced LV cardiomyocyte [Ca2+]i and diastolic sarcomere dynamics compared to WKY, indicating successful HT compensation without HA.
  • WKHA and SHR rats exhibited similar, slightly reduced [Ca2+]i dynamics compared to WKY.
  • SHR displayed significantly reduced systolic and diastolic sarcomere dynamics, more pronounced in males, suggesting impaired function beyond HT.

Conclusions:

  • Hypertension alone is insufficient to explain LV hypertrophy and diminished cardiomyocyte function in SHR.
  • Hyperactivity, particularly in males, interacts with hypertension in SHR to impair cardiomyocyte function.
  • This interaction may override compensatory mechanisms present in hypertension without hyperactivity.

Related Concept Videos

Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...